NDAOPHTHALMICSOLUTION/DROPS
Approved
Jul 1969
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
PAREDRINE (hydroxyamphetamine hydrobromide) by PhotoPharmics is clinical pharmacology paremyd solution combines the effects of the adrenergic agent, hydroxyamphetamine hydrobromide, and the anticholinergic agent, tropicamide. First approved in 1969.
Drug data last refreshed 33m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Paredrine (hydroxyamphetamine hydrobromide) is an indirectly-acting sympathomimetic ophthalmic solution used for mydriasis (pupil dilation) during eye examinations. The drug works by releasing endogenous norepinephrine from adrenergic nerve terminals, and is often combined with tropicamide to achieve additive mydriatic and cycloplegic effects. It facilitates ophthalmoscopy by producing diminished pupil responsiveness to light.
LOE Approaching
Product is in late-stage lifecycle with LOE approaching, suggesting limited expansion opportunities and focus on retention strategies within a mature, specialty ophthalmic portfolio.
Mechanism of Action
CLINICAL PHARMACOLOGY PAREMYD Solution combines the effects of the adrenergic agent, hydroxyamphetamine hydrobromide, and the anticholinergic agent, tropicamide. Hydroxyamphetamine hydrobromide is an indirectly-acting sympathomimetic agent which, when applied topically to the eye, causes the…
Indications
Worked on PAREDRINE at PhotoPharmics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.